NUVILEX, INC.

New Filing
CIK: 0001157075·Biotechnology·NEVADA·Filed: Dec 27, 2013
Total Offering

$3,500,000

Amount Sold

$1,136,000

Investors

21

First Sale

Apr 27, 2012

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
Yes

Related Persons

NameRole
Kenneth L. Waggoner
Related Person
Patricia Gruden
Related Person
Gerald W. Crabtree
Related Person
Robert F. Ryan
Related Person
Timothy Matula
Related Person
Robert Bowker
Related Person
Richard M. Goldfarb
Related Person

Company

PharmaCyte Biotech, Inc.

12510 PROSPERITY DRIVE, SUITE 310

SILVER SPRING, MD, 20904-1643

(917) 595-2850

SEC Filing

0001019687-13-005003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
NUVILEX, INC. Form D Filing — $3,500,000 | FilingFlow